Fig. 2From: A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndromeComparison of responder rates between two groups, as defined by a 50-point or more reduction in IBS-SSS overall score at the end of the study period (P-value = 0.01)Back to article page